Neuraxpharm Group, a European specialty pharmaceutical company focused on the treatment of central nervous system disorders (CNS), has acquired Farmax, a CNS specialty pharmaceutical company, from SVUS Pharma, it was reported yesterday.

Farmax has been renamed Neuraxpharm Bohemia and will commercialise its products under the Neuraxpharm brand. Neuraxpharm Bohemia plans to offer new and differentiated products to local patients and healthcare providers based on the group's broad CNS range.

The terms of the deal were not revealed.